comparemela.com

Latest Breaking News On - Society for immunotherapy of cancer annual meeting - Page 1 : comparemela.com

Theriva Biologics, Inc. (NYSE:TOVX) Q4 2023 Earnings Call Transcript

Theriva Biologics, Inc. beats earnings expectations. Reported EPS is $-0.34, expectations were $-0.41. Theriva Biologics, Inc.

United-states
Spain
America
Steven-shallcross
Theriva-biologics
Manel-cascallo
Chris-calabrese
Vince-wacher
James-molloy
Alliance-global-partners
Washington-university
Product-development-of-theriva-biologics

Fate Therapeutics Announces Initiation of Phase 1 Clinical Trial for FT825 / ONO-8250 in Patients with HER2-expressing Advanced Solid Tumors

08.01.2024 - iPSC-derived CAR T-cell Product Candidate Incorporates Seven Synthetic Controls of Cell Function including a Novel HER2-targeted Antigen Binding Domain Phase 1 Study is Being Conducted in Collaboration with Ono Pharmaceutical SAN DIEGO, Jan. 08, . Seite 1

Scott-wolchko
Fate-therapeutics-inc
Society-for-immunotherapy-of-cancer-annual-meeting
Nasdaq
Ono-pharmaceutical-co-ltd
Chief-executive-officer
Cancer-annual-meeting
Fate-therapeutics-chart
Ate-therapeutics-kurs
Ate-therapeutics-aktie

FDA Grants Fast Track Designation to CAN-2409 For Pancreatic Cancer

The Food and Drug Administration (FDA) has granted Fast Track Designation to the investigational adenovirus CAN-2409 plus prodrug Valtrex for the treatment of patients with pancreatic ductal adenocarcinoma.

Pancreatic-cancer-action-network
National-cancer-institute
Drug-administration
Society-for-immunotherapy-of-cancer-annual-meeting
Fast-track-designation
Candel-therapeutics
Cancer-annual-meeting
Paul-peter-tak
Pancreatic-cancer-action
Opioids-reduce-misuse-after-pancreatic-cancer
Track-designation

Carisma Therapeutics (CARM) Announces FDA Clearance of IND Application for CT-0525

Carisma Therapeutics (CARM) Announces FDA Clearance of IND Application for CT-0525
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Steven-kelly
Michael-klichinsky
Society-for-immunotherapy-of-cancer-annual-meeting
Carisma-therapeutics-inc
Nasdaq
Drug-administration
Carisma-therapeutics
Investigational-new-drug
Study-may-proceed
Chief-executive-officer
Annual-meeting
Chief-scientific-officer

Carisma Therapeutics Announces FDA Clearance of IND Application for CT-0525, a Novel HER2-Targeting CAR-Monocyte

Carisma Therapeutics Announces FDA Clearance of IND Application for CT-0525, a Novel HER2-Targeting CAR-Monocyte
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Philadelphia
Pennsylvania
United-states
Michael-klichinsky
Steven-kelly
Society-for-immunotherapy-of-cancer-annual-meeting
Nasdaq
Exchange-commission
Carisma-therapeutics-inc
Company-quarterly-report-on-form
Prnewswire-carisma-therapeutics-inc
Drug-administration

vimarsana © 2020. All Rights Reserved.